Hot Papers

Date: January 6, 1992, pp.16 C.A. Smith, T. Davis, D. Anderson, L. Solam, et al., "A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins," Science, 248:1019- 23, 1990. (MOLECULAR BIOLOGY) Craig Smith (Immunex Corp., Seattle): "There are three reasons why the molecular cloning of this tumor necrosis factor (TNF) receptor has turned out to be a reasonable milestone. "First, there is the intrinsic scientific interest. TNF is an outstanding mediator of ho


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share


Date: January 6, 1992, pp.16

C.A. Smith, T. Davis, D. Anderson, L. Solam, et al., "A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins," Science, 248:1019- 23, 1990. (MOLECULAR BIOLOGY) Craig Smith (Immunex Corp., Seattle):

"There are three reasons why the molecular cloning of this tumor necrosis factor (TNF) receptor has turned out to be a reasonable milestone.

"First, there is the intrinsic scientific interest. TNF is an outstanding mediator of host immune defense whose signal transduction mechanisms have been impossible to investigate without a cloned receptor.

"Further, the receptor's unusual sequence also defined an emerging superfamily of transmembrane proteins that network important elements of both the immune and nervous systems. The low-affinity nerve growth-factor receptor and the TNF receptor are only two of eight currently known family members. There seems little question, therefore, that this newest of gene superfamilies figures predominantly in the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide